In this review:
Patterns of cellular pathologies in neurodegenerative disease of the brain
Monogenic hyperkinestic disorders with pleomorphic phenotypes
The Huntington’s disease gene and its modifiers
Emerging therapies in Huntington’s disease
MDS criteria for diagnosis of progressive supranuclear palsy
Translating LRRK2 biology into novel therapies
The gut microbiome and Parkinson’s disease
Challenges in clinicogenetic correlations: diagnosis & treatment
Impulse control disorders in Parkinson’s disease
Deutetrabenazine for the treatment of tardive dyskinesia
Please login below to download this issue (PDF)